Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial ...

An international, multi-site clinical study led by an Indiana University School of Medicine researcher and anesthesiologist ...

Arch Biopartners has initiated subject recruitment in its Phase II study aimed at assessing cilastatin’s efficacy in ...

Healthcare offers diverse career paths beyond traditional clinical roles like doctors and nurses. Opportunities abound in ...

Abivax SA (NASDAQ:ABVX) shares surged in post-market trading Tuesday after the French biotech firm announced successful Phase 3 trial results for its ulcerative colitis treatment, obefazimod. The oral ...

Nightly sleep duration greater than 9.9 hours in the first week postconcussion is associated with higher symptom burden among adolescents.

Dr. Iwasaki is internationally recognized for her groundbreaking research on viral pathogenesis, human immunobiology, and post-viral chronic conditions, including Long COVID and COVID-19 ...

Alva Health CEO and Mexican immigrant Sandra Saldana aims to provide early detection for a leading cause of death and ...

The UK government recently unveiled its 10-year Life Sciences Sector Plan, putting forward a comprehensive strategy for transforming the UK into ...

"Personalisation has long been the holy grail of beauty," says Delhi-based dermatologist, Dr. Shalini Bannerjee. "What’s exciting—and slightly unnerving—is how AI can scale that personalisation to the ...

Read this article to consider whether trying to prevent infections stops us from making healthcare more sustainable.

Herbs like ashwagandha and turmeric are now widely recognized as part of the global wellness lexicon. But ayurveda, India’s ...